Importer of Controlled Substances Application: Fisher Clinical Services, Inc., 49550 [2019-20413]
Download as PDF
<![CDATA[
49550
Federal Register / Vol. 84, No. 183 / Friday, September 20, 2019 / Notices
Dated: September 11, 2019.
Julie H. Ernstein,
Supervisory Archeologist, National Register
of Historic Places/National Historic
Landmarks Program.
Dated: August 20, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
Dated: August 20, 2019.
Neil D. Doherty,
Acting, Assistant Administrator.
[FR Doc. 2019–20417 Filed 9–19–19; 8:45 am]
[FR Doc. 2019–20413 Filed 9–19–19; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[FR Doc. 2019–20375 Filed 9–19–19; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
[Docket No. DEA–392]
Drug Enforcement Administration
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Globyz Pharma, LLC
ACTION:
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 21, 2019. Such
persons may also file a written request
for a hearing on the application on or
before October 21, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on June 4, 2019, Globyz
Pharma, LLC, 2101 Market Street, Suite
5, Boothwyn, Pennsylvania 19061–4001
applied to be registered as an importer
of the following basic classes of
controlled substance:
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug
code
Schedule
Oxycodone ...............
9143
II
The company plans to import the
listed controlled substance to complete
analytical testing.
VerDate Sep<11>2014
17:13 Sep 19, 2019
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 21, 2019. Such
persons may also file a written request
for a hearing on the application on or
before October 21, 2019.
Jkt 247001
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 19, 2019, Fisher
Clinical Services, Inc., 7554 Schantz
Road, Allentown, Pennsylvania 18106
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Psilocybin .................
Methylphenidate .......
Levorphanol ..............
Noroxymorphone ......
Tapentadol ................
Drug
code
7437
1724
9220
9668
9780
Schedule
I
II
II
II
II
The company plans to import the
listed controlled substances for clinical
trials only.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
ACTION:
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUMMARY:
Notice of application.
DATES:
Notice of application.
Importer of Controlled Substances
Registration
Companies
FR Docket
Published
Sigma Aldrich
Co., LLC.
84 FR 31620
July 2, 2019.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I and II controlled substances
to the above listed companies.
Dated: August 23, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019–20416 Filed 9–19–19; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 84, Number 183 (Friday, September 20, 2019)]
[Notices]
[Page 49550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20413]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Fisher Clinical
Services, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before October 21, 2019.
Such persons may also file a written request for a hearing on the
application on or before October 21, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 19, 2019, Fisher Clinical Services, Inc., 7554
Schantz Road, Allentown, Pennsylvania 18106 applied to be registered as
an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Psilocybin............................ 7437 I
Methylphenidate....................... 1724 II
Levorphanol........................... 9220 II
Noroxymorphone........................ 9668 II
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
clinical trials only.
Dated: August 20, 2019.
Neil D. Doherty,
Acting, Assistant Administrator.
[FR Doc. 2019-20413 Filed 9-19-19; 8:45 am]
BILLING CODE 4410-09-P
